🦊/Lists

Biotech Investors & VC Firms in Asia-Pacific

571 firms in this list, with a median first check of $650K. 110 of them lead rounds. Generated from verified public data and updated continuously.

Innovestor Ventures
HelsinkiPre-Seed–Growth$270K – $3.2M
29 people
Flucas Ventures
JupiterSeed–Series A$100K – $5M
1 person
Polaris Partners
BostonSeed–Growth$500K – $5M
48 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
47 people
SOSV
New YorkPre-Seed–Series B$30K – $550K
30 people
VU Venture Partners
San FranciscoSeed–Series B$200K – $1M
40 people
HOF Capital
New YorkPre-Seed–Growth$25K – $15M
39 people
Advent International
BostonSeries A–Late Stage$1.1B
62 people
TPG
San FranciscoGrowth–Late Stage
53 people
Sixth Street
San FranciscoPre-Seed–Late Stage$50M – $2.5B
44 people
MPM BioImpact
BostonPre-Seed–Late Stage$1M – $15M
50 people
Celesta Capital
Menlo ParkSeed–Late Stage$5M – $20M
33 people
Big Idea Ventures
New YorkPre-Seed–Seed$125K – $2.5M
14 people
Sofina
BrusselsSeed–Late Stage$100M – $300M
57 people
Premji Invest
Menlo ParkSeed–Late Stage
35 people
Clairvest Group Inc
TorontoGrowth–Late Stage$25M – $100M
58 people
Anzu Partners
BillericaPre-Seed–Growth
49 people
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
12 people
Joyance Partners
BerlinPre-Seed–Series A
32 people
Metaplanet
TallinnSeed–Late Stage$500K – $10M
6 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
22 people
Korys
HalleSeries A–Late Stage$5.4M
40 people
Prosperity7 Ventures
DhahranSeries A–Growth
41 people
AgFunder
San FranciscoSeed–Growth$10K – $5M
24 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.